Profile and outcome of receptor conversion in breast cancer metastases: a nation‐wide multicenter epidemiological study

2020 ◽  
Vol 148 (3) ◽  
pp. 692-701
Author(s):  
Zong‐Bi Yi ◽  
Pei Yu ◽  
Su Zhang ◽  
Wen‐Na Wang ◽  
Yi‐Qun Han ◽  
...  
2018 ◽  
Vol 110 (6) ◽  
pp. 568-580 ◽  
Author(s):  
Willemijne A M E Schrijver ◽  
Karijn P M Suijkerbuijk ◽  
Carla H van Gils ◽  
Elsken van der Wall ◽  
Cathy B Moelans ◽  
...  

2009 ◽  
Author(s):  
L. Hoefnagel ◽  
E. van der Wall ◽  
M. van de Vijver ◽  
P. van Diest

2010 ◽  
Vol 12 (5) ◽  
Author(s):  
Laurien DC Hoefnagel ◽  
Marc J van de Vijver ◽  
Henk-Jan van Slooten ◽  
Pieter Wesseling ◽  
Jelle Wesseling ◽  
...  

Cancer ◽  
2012 ◽  
Vol 118 (20) ◽  
pp. 4929-4935 ◽  
Author(s):  
Laurien D. C. Hoefnagel ◽  
Cathy B. Moelans ◽  
S. L. Meijer ◽  
Henk-Jan van Slooten ◽  
Pieter Wesseling ◽  
...  

2009 ◽  
Vol 69 (05) ◽  
Author(s):  
EC Schest ◽  
H Cerwenka ◽  
A El-Shabrawi ◽  
H Bacher ◽  
HJ Mischinger

2019 ◽  
Author(s):  
K Horas ◽  
M Abraham ◽  
F Jakob ◽  
R Ebert ◽  
G Maier ◽  
...  

2019 ◽  
Author(s):  
Shahan Mamoor

Differential gene expression analysis of multiple datasets, in mice and in men revealed that transcripts of the olfactomedin-like family are differentially expressed in metastases, both in patients with breast cancer and in genetically engineered mouse models of breast cancer. The expression of olfactomedin-like genes was perturbed in metastases to the bone, brain and the lung, suggesting that these molecules function in the metastatic process rather than having tissue-specific associations with the site of dissemination. The olfactomedin-like family may play a role in the progression of breast cancer from frank tumor to colonization of distant organ sites.


Sign in / Sign up

Export Citation Format

Share Document